Biologics and Biosimilars market is expected to 297100 million US$ by the end of 2025, growing at a CAGR of 4.5%

This report studies the Biologics and Biosimilars market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Request Sample@
https://www.qyresearch.com/sample-form/form/493146/global-biologics-and-biosimilars-market

For Discount, Customization:
https://www.qyresearch.com/customize-request/form/493146/global-biologics-and-biosimilars-market

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.
Most of biologics manufacturer are concentrated in US, Germany,UK and other developed countries. But in biosimilars industry the situation is different, manufacturer in developing countries play a very important role.
Through the research we tend to believe that the growth of biologics industry maybe slow but high profits during the period of patent may attractive. As to biosimilars, now is a changce for newcomers and they will greatly change the industry.

The global Biologics and Biosimilars market was 209400 million US$ in 2017 and is expected to 297100 million US$ by the end of 2025, growing at a CAGR of 4.5% between 2018 and 2025.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Biologics and Biosimilars in these regions, from 2013 to 2025, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen

Contact Us:-

QY Research, INC.
17890 Castleton,
Suite 218,
Los Angeles, CA – 91748
USA: +1 626 295 2442
Email:
enquiry@qyresearch.com

Web:
http://www.qyresearch.com

-

This release was published on openPR.